Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
 
Advanced search:
Enter Search Keyword
 
Filter your search by:
Industry
Country
Publish date
Search By Price Range
From:$
    To:$
 
Insight Pharma Reports
Results 1-10 of 14  1 2 >  Sort By :
Title Date Price
Commercializing Novel IVDs: A Comprehensive Manual for Success
By Insight Pharma Reports
Does your company have an idea for a novel biomarker test, but you’re unsure what the market potential will be? Have you invented a more sensitive test to diagnose a common autoimmune disorder, ...Read More
Jan 2017 $1595.00
Gene Therapy: Moving Toward Commercialization
By Insight Pharma Reports
Executive Summary Insight Pharma Reports’ Gene Therapy: Moving Toward Commercialization”, outlines the progress of the gene therapy field since its inception in the 1970s, with a special f ...Read More
Nov 2015 $2492.00
Cancer Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies
By Insight Pharma Reports
Overview of the Report: This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the min ...Read More
Sep 2014 $2495.00
Biomarkers in Alzheimers Disease
By Insight Pharma Reports
Biomarkers in Alzheimer’s Disease is focused on the biomarker identification and development in patients with Alzheimer’s Disease. As a spin-off of Biomarkers: Discovery and Development fo ...Read More
Aug 2014 $699.00
Biomarkers in Amyotrophic Lateral Sclerosis
By Insight Pharma Reports
Biomarkers in Amyotrophic Lateral Sclerosis is focused on the biomarker identification and development in patients with Amyotrophic Lateral Sclerosis (ALS). As a spin-off of Biomarkers: Discovery and ...Read More
Aug 2014 $699.00
Biomarkers in Parkinsons Disease
By Insight Pharma Reports
Executive Summary Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders, particularly Parkinson’s Disease. Although th ...Read More
Aug 2014 $699.00
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders
By Insight Pharma Reports
Biomarkers: Discovery and Development for a Diagnostic Approach to Neurodegenerative Disorders has a focus in biomarkers for neurodegenerative diseases and diagnostic applications in development. Biom ...Read More
Jul 2014 $2495.00
Vaccines: The End of Illness
By Insight Pharma Reports
New to Insight Pharma Reports is Vaccines: The End of Illness. This report focuses on the most recent vaccine research, emphasizing their reputation as an unmatched tool of efficient healthcare. Their ...Read More
Apr 2014 $2495.00
MicroRNA: An Insight to miRNA-based microarrays, diagnostics and therapeutics
By Insight Pharma Reports
New to Insight Pharma Reports is: MicroRNA: An Insight to miRNA-Based Microarrays, Diagnostics and Therapeutics. This report covers the specifics of microRNA (miRNA) as it is a relatively new space in ...Read More
Apr 2014 $2495.00
Digital Pathology Insights: Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks
By Insight Pharma Reports
New to Insight Pharma Reports is Digital Pathology Insights:  Imaging Technologies, Expert Perspectives, Standardization, and Current Outlooks. This report delves into the rapidly evolving field ...Read More
Apr 2014 $2495.00
Results 1-10 of 14  1 2 > 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z